HIV pre-exposure prophylaxis (PrEP) awareness and acceptability among trans women: a review

ABSTRACT Transgender (trans) women are disproportionally burdened by the HIV epidemic due to complex structural, psychosocial and biological factors. HIV pre-exposure prophylaxis (PrEP) is a biomedical prevention approach for people at substantial risk of acquiring HIV. This literature review assessed awareness, willingness to use, and barriers and facilitators for PrEP acceptability among trans women. A search was conducted through five databases and included studies with primary data and disaggregate results for trans women. Of 255 retrieved citations, 17 met the inclusion criteria and were included. Low to moderate knowledge about PrEP was observed among studies. However, willingness to use PrEP was predominantly high. Frequent barriers to PrEP acceptability included concerns about side effects, cost, hormone therapy, adherence, PrEP-related stigma and interaction with healthcare workers. Facilitators included perceived reduction of HIV risk, fear of HIV/AIDS and reduced dependence on partners. Findings suggest elevated interest in PrEP and highlight important barriers and facilitators that should be specifically addressed to optimize PrEP uptake and use among this highly vulnerable population.

[1]  R. Pant,et al.  Pre‐exposure prophylaxis: awareness, acceptability and risk compensation behaviour among men who have sex with men and the transgender population , 2018, HIV medicine.

[2]  R. D. De Boni,et al.  Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study. , 2018, The lancet. HIV.

[3]  S. Golub,et al.  PrEP Stigma: Implicit and Explicit Drivers of Disparity , 2018, Current HIV/AIDS Reports.

[4]  W. El-Sadr,et al.  Limited awareness of pre-exposure prophylaxis among black men who have sex with men and transgender women in New York city , 2018, AIDS care.

[5]  C. Fairley,et al.  A Global Estimate of the Acceptability of Pre-exposure Prophylaxis for HIV Among Men Who have Sex with Men: A Systematic Review and Meta-analysis , 2018, AIDS and Behavior.

[6]  Zixin Wang,et al.  Acceptability of Daily Use of Free Oral Pre-exposure Prophylaxis (PrEP) Among Transgender Women Sex Workers in Shenyang, China , 2017, AIDS and Behavior.

[7]  Z. Oo,et al.  Willingness to use HIV pre-exposure prophylaxis among gay men, other men who have sex with men and transgender women in Myanmar , 2017, Journal of the International AIDS Society.

[8]  F. Barg,et al.  Young Transgender Women's Attitudes Toward HIV Pre-exposure Prophylaxis. , 2017, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[9]  W. Mcfarland,et al.  Unveiling of HIV dynamics among transgender women: a respondent-driven sampling study in Rio de Janeiro, Brazil. , 2017, The lancet. HIV.

[10]  H. Leufkens,et al.  Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns , 2017, Drug Safety.

[11]  Aerielle M. Allen,et al.  Stigma and Conspiracy Beliefs Related to Pre-exposure Prophylaxis (PrEP) and Interest in Using PrEP Among Black and White Men and Transgender Women Who Have Sex with Men , 2017, AIDS and Behavior.

[12]  R. Stall,et al.  A Multi-US City Assessment of Awareness and Uptake of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Black Men and Transgender Women Who Have Sex with Men , 2017, Prevention Science.

[13]  V. Veloso,et al.  Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil , 2017, AIDS and Behavior.

[14]  B. Marshall,et al.  High Willingness to Use HIV Pre-Exposure Prophylaxis Among Transgender Women in Argentina , 2016, Transgender health.

[15]  ZalazarVirginia,et al.  High Willingness to Use HIV Pre-Exposure Prophylaxis Among Transgender Women in Argentina. , 2016 .

[16]  R. Grant,et al.  The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices , 2016, Journal of the International AIDS Society.

[17]  R. Stall,et al.  HIV Pre-exposure Prophylaxis Indication and Readiness Among HIV-Uninfected Transgender Women in Ho Chi Minh City, Vietnam , 2016, AIDS and Behavior.

[18]  R. Grant,et al.  Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis , 2016, Journal of acquired immune deficiency syndromes.

[19]  Madeline B. Deutsch,et al.  Integrated and Gender-Affirming Transgender Clinical Care and Research , 2016, Journal of acquired immune deficiency syndromes.

[20]  R. Grant,et al.  Effectiveness and safety of oral HIV preexposure prophylaxis for all populations , 2016, AIDS.

[21]  J. Keatley,et al.  ‘I am not a man’: Trans-specific barriers and facilitators to PrEP acceptability among transgender women , 2016, Global public health.

[22]  Sheena McCormack,et al.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial , 2016, The Lancet.

[23]  J. Haberer.  Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice , 2016, Current opinion in HIV and AIDS.

[24]  S. Reisner,et al.  Correlates of PrEP Indication in a Multi-Site Cohort of Young HIV-Uninfected Transgender Women , 2016, Aids and Behavior.

[25]  David Thompson,et al.  On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. , 2015, The New England journal of medicine.

[26]  D. Glidden,et al.  HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial , 2015, The lancet. HIV.

[27]  Al Liu,et al.  Knowledge, Indications and Willingness to Take Pre-Exposure Prophylaxis among Transwomen in San Francisco, 2013 , 2015, PloS one.

[28]  B. Marshall,et al.  Inclusion of trans women in pre-exposure prophylaxis trials: a review , 2015, AIDS care.

[29]  K. Fiereck.  Cultural conundrums: the ethics of epidemiology and the problems of population in implementing pre-exposure prophylaxis. , 2015, Developing world bioethics.

[30]  R. Baggaley,et al.  Young key populations and HIV: a special emphasis and consideration in the new WHO Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations , 2015, Journal of the International AIDS Society.

[31]  Megha L Mehrotra,et al.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. , 2014, The Lancet. Infectious diseases.

[32]  S. Reisner,et al.  HIV epidemics among transgender women , 2014, Current opinion in HIV and AIDS.

[33]  Gloria N. Nwagwu.  A phenomenological study of acceptability of preexposure prophylaxis therapy within the lived experiences of HIV negative male-to-female transgender young adults , 2014 .

[34]  C. Beyrer,et al.  Acceptability of Pre-Exposure Prophylaxis among Men Who Have Sex with Men and Transgender Women in Northern Thailand , 2013, PloS one.

[35]  C. Hendrix,et al.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial , 2013, The Lancet.

[36]  C. Beyrer,et al.  Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. , 2013, The Lancet. Infectious diseases.

[37]  John T Brooks,et al.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. , 2012, The New England journal of medicine.

[38]  James D. Campbell,et al.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.

[39]  W. J. Meyer,et al.  Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 , 2012 .

[40]  Robert Garofalo,et al.  Syndemic theory and HIV-related risk among young transgender women: the role of multiple, co-occurring health problems and social marginalization. , 2012, American journal of public health.

[41]  David V Glidden,et al.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.

[42]  K. Underhill,et al.  Sex Work and HIV Status Among Transgender Women: Systematic Review and Meta-Analysis , 2008, Journal of acquired immune deficiency syndromes.

[43]  R. Melendez,et al.  ‘It's really a hard life’: Love, gender and HIV risk among male‐to‐female transgender persons , 2007, Culture, health & sexuality.

[44]  T. Finlayson,et al.  Estimating HIV Prevalence and Risk Behaviors of Transgender Persons in the United States: A Systematic Review , 2007, AIDS and Behavior.

[45]  Kempner Me.  Sexuality education is debated as restrictive programs gain popularity. , 2000 .